Hindustan Foods Ltd Q4 FY26 Earnings Analysis

- Company avoids giving revenue guidance as revenues are largely pass-through due to raw material/packing costs and GST complexities; focuses on PAT guidance instead. - FY '27 PAT guidance is INR 200-220 crores, approx. 1.4x growth over FY '26, driven by ramp-up and normalization of commissioned assets. - Volume growth expected from increased utilization of new or underutilized assets, especially ramping up in FY '27 and continuing into FY '28. - International business and new segments (e.g., shoes, OTC Pharma, ice cream) show optimism with expected growth as supply chains and trade agreements stabilize. - Operational leverage and efficiency improvements contribute to profitability even if revenue guidance is avoided. - Capex and capacity expansions across categories underpin a targeted long-term growth rate of around 20% annually, supported by 1:1 leveraged operating cash flows. - Sustainability and responsible operations also factor into scalable growth plans.

- FY '27 PAT guidance is INR 200-220 crores, about 1.4x growth over FY '26 (~50% increase), driven mainly by asset ramp-up and operating leverage. - Revenue growth guidance is avoided due to pass-through nature and GST complications; focus is on profitability. - Operating leverage will accelerate as commissioned or underutilized assets achieve better utilization in FY '27 and beyond. - Profit growth expected to continue beyond FY '27, with further asset commercialization and ramp-up in FY '28 improving earnings. - Company targets 18-20% ROCE sustainably, supported by disciplined capex and capital allocation. - Ongoing investments and geographical expansion expected to fuel future profitability, particularly in segments like ice cream and shoes. - Cash flow generation and debt management aligned with growth; capex funded prudently with a target debt-equity of 1:1 to support continued expansion. - Seasonality in ice cream impacts quarterly timing but annual profitability remains protected regardless of seasonal variations.

- The company continues an active capex journey beyond FY '26 with no intention to pause investments. - For FY '27, an announced capex includes an INR 50 crore project in the HPC segment, with further projects in lead pipeline pending finalization. - Total gross block expected to reach around INR 780 crores by FY '26-end; roughly INR 200 crores already commissioned. - Investments include capacity expansions like doubling Mysuru factory capacity and an ice cream cone manufacturing facility acquisition. - New investments focus on expanding across all 5 business units, including ice creams, food & beverages (F&B), and beverages, with plans to increase beverage production to 250,000 kL. - Capital allocation disciplined, targeting minimum 18% ROCE; current adjusted ROCE at 19%. - Funding through a mix of internal accruals, debt, and preferential equity issuance, maintaining comfortable leverage with net debt to equity at 0.77x. - Ongoing discussions with customers to shift some commercial models to conversion-based to optimize working capital amid GST changes.

- The company continues to invest in new projects and capex, indicating ongoing funding needs. - Capex is funded through a prudent mix of internal accruals, debt, and preferential equity issuance, maintaining balance sheet resilience. - The management expects to continue taking on project debt at a 1:1 debt-to-operating cash flow ratio to support around 20% growth per year. - No new capex announcements beyond the signed projects; additional investments depend on green lights for new deals. - The company remains conservative with debt, sticking to traditional project loans rather than experimenting with new or forex-denominated debt. - Net debt is currently stable but not expected to decrease drastically in the coming years due to ongoing investments. - If investments pause, the company plans to return money to shareholders via dividends. - Discussions with customers about transitioning to conversion-based business models may affect reported revenue but not absolute profitability.

The transcript does not provide explicit details on the current or expected orderbook/pending orders for Hindustan Foods Limited. However, some relevant points related to business outlook and capacity utilization include: - Approximately INR 200 crores of capital is yet to be ramped up or underutilized, with additional capital work in progress (CWIP) and advances. - The Panipat project is expected to commercialize by Q1 FY '27 but will reach normalized utilization in FY '28 due to seasonality. - The company is optimistic about continuing the pace of capex and is working on multiple leads for further investments. - New international business division set up, targeting export growth, especially in footwear and OTC pharma segments. - The shoe business is positioned to benefit from improved trade treaties, with a lead time of 6-8 months before order volumes translate into revenue. No specific numeric data on orderbook or pending orders was disclosed.